A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic?

by Victoria Pilkington, Toby Pepperrell, Andrew Hill
Published 2020-04-01

Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs

by Florence Rodgers, Toby Pepperrell, Sarai Keestra, Victoria Pilkington
Published 2021-01-01

Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19

by Toby Pepperrell, Victoria Pilkington, Andrew Owen, Junzheng Wang, Andrew M. Hill
Published 2020-04-01

Making a COVID-19 vaccine that works for everyone: ensuring equity and inclusivity in clinical trials

by Toby Pepperrell, Florence Rodgers, Pranav Tandon, Kelly Sarsfield, Molly Pugh-Jones, Theo Rashid, Sarai Keestra
Published 2021-01-01

Phase 3 trials of new antiretrovirals are not representative of the global HIV epidemic

by Toby Pepperrell, Andrew Hill, Michelle Moorhouse, Polly Clayden, Kaitlyn McCann, Simiso Sokhela, Celicia Serenata, Willem Daniel Francois Venter
Published 2020-04-01